Products for Research Use Only
RegisterLogin

SML-8-73-1

CAT: 0804-HY-19315Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-19315Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
SML-8-73-1 is a nucleotide-based KRASG12C inhibitor. SML-8-73-1 can be used for the study of non-small cell lung cancer (NSCLC) [1][2].
CAS Number
1536470-92-4
UNSPSC
12352005
Target
Ras
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Field of Research
Cancer
Smiles
O=C1C(N=CN2[C@@H]3O[C@H](COP(OP(OCCNC(CCl)=O)(O)=O)(O)=O)[C@@H](O)[C@H]3O)=C2N=C(N)N1
Molecular Formula
C14H21ClN6O12P2
Molecular Weight
562.75
References & Citations
[1]Lim SM, et al. Therapeutic targeting of oncogenic K-Ras by a covalent catalytic site inhibitor. Angew Chem Int Ed Engl. 2014 Jan 3;53 (1) :199-204.|[2]Huang L, Guo Z, Wang F, Fu L. KRAS mutation: from undruggable to druggable in cancer. Signal Transduct Target Ther. 2021 Nov 15;6 (1) :386.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
K-Ras

Related Products

CatalogName
HY-164389SML-10-70-1
HY-130558SL-1-73
HY-161924HIV-1 inhibitor-73
HY-161677PD-L1/CD-73-IN-1
HY-161688HDAC-IN-73
HY-163980AChE-IN-73
HY-157722HSD17B13-IN-73
HY-151882EGFR-IN-73
HY-122214-01AC-73
HY-161999α-Glucosidase-IN-73

Alternative Products

CatalogName
GTR19273761-01SML-8-73-1
MBS5813018SML-10-70-1
30200PTHrP-IRMA[SML]
C2088-64Caspase 12 (Sml)
TPL0032-01Compound 30486-73-8
ANTY021307Keratin 8 (Ab-73)
YB-FYU-002-SMLYB-FYU-002-SML
C2088-64ACaspase 12 (Sml) (Control Peptide)
Y021307Anti-Keratin 8 (Ab-73)
MBS858808-01Keratin 8 (Ab-73) Antibody

Popular Products